梁瑞鹏, 赵彤, 展鹏, 刘新泳. 西尼罗病毒抑制剂研究进展J. 药学学报, 2020,55(4): 763-772. doi: 10.16438/j.0513-4870.2019-1017
引用本文: 梁瑞鹏, 赵彤, 展鹏, 刘新泳. 西尼罗病毒抑制剂研究进展J. 药学学报, 2020,55(4): 763-772. doi: 10.16438/j.0513-4870.2019-1017
LIANG Rui-peng, ZHAO Tong, ZHAN Peng, LIU Xin-yong. Research progress on the West Nile virus inhibitorsJ. Acta Pharmaceutica Sinica, 2020,55(4): 763-772. doi: 10.16438/j.0513-4870.2019-1017
Citation: LIANG Rui-peng, ZHAO Tong, ZHAN Peng, LIU Xin-yong. Research progress on the West Nile virus inhibitorsJ. Acta Pharmaceutica Sinica, 2020,55(4): 763-772. doi: 10.16438/j.0513-4870.2019-1017

西尼罗病毒抑制剂研究进展

Research progress on the West Nile virus inhibitors

  • 摘要: 西尼罗病毒是一种由库蚊传播的黄病毒。人们对其普遍易感,病毒感染可导致西尼罗热,进而发展为西尼罗病毒性脑炎甚至导致死亡。目前尚无批准的特异性抗西尼罗病毒药物。因此,研发有效的西尼罗病毒抑制剂是目前药物化学研究的热点。本文根据西尼罗病毒的主要靶点,总结了西尼罗病毒抑制剂研究的新进展。

     

    Abstract: West Nile virus is a flavivirus transmitted by culex mosquitoes. People are generally susceptible to it, West Nile virus infection can cause west Nile fever, which can develop West Nile viral encephalitis and even lead to death. There are currently no approved specific antiviral drugs against West Nile virus. Therefore, seeking effective West Nile virus inhibitors is a hot topic in current community of medicinal chemistry. In this article, based on the main targets of West Nile virus, we summarize the new progress research on West Nile virus inhibitors.

     

/

返回文章
返回